Human Gene IDO1 (ENST00000518237.6_4) from GENCODE V47lift37
  Description: indoleamine 2,3-dioxygenase 1 (from RefSeq NM_002164.6)
Gencode Transcript: ENST00000518237.6_4
Gencode Gene: ENSG00000131203.13_13
Transcript (Including UTRs)
   Position: hg19 chr8:39,771,410-39,786,309 Size: 14,900 Total Exon Count: 10 Strand: +
Coding Region
   Position: hg19 chr8:39,771,442-39,785,704 Size: 14,263 Coding Exon Count: 10 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr8:39,771,410-39,786,309)mRNA (may differ from genome)Protein (403 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedReactome
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: I23O1_HUMAN
DESCRIPTION: RecName: Full=Indoleamine 2,3-dioxygenase 1; Short=IDO-1; EC=1.13.11.52; AltName: Full=Indoleamine-pyrrole 2,3-dioxygenase;
FUNCTION: Catalyzes the cleavage of the pyrrol ring of tryptophan and incorporates both atoms of a molecule of oxygen.
CATALYTIC ACTIVITY: D-tryptophan + O(2) = N-formyl-D-kynurenine.
CATALYTIC ACTIVITY: L-tryptophan + O(2) = N-formyl-L-kynurenine.
COFACTOR: Binds 1 heme group per subunit.
ENZYME REGULATION: Activity is inhibited by and MTH-trp (methylthiohydantoin-DL-tryptophan), modestly inhibited by L-1MT (1-methyl-L-tryptophan) but not D-1MT (1-methyl-D-tryptophan).
BIOPHYSICOCHEMICAL PROPERTIES: Kinetic parameters: KM=21.23 uM for L-tryptophan; KM=4.6 mM for D-tryptophan; Note=Catalytic efficiency for L-tryptophan is 150 times higher than for D-tryptophan;
PATHWAY: Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2.
INDUCTION: By IFNG/IFN-gamma.
SIMILARITY: Belongs to the indoleamine 2,3-dioxygenase family.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: IDO1
Diseases sorted by gene-association score: listeriosis (12), bladder disease (10), trypanosomiasis (10), chlamydia (10), eczema herpeticum (8), ascariasis (7), headache (7), toxic oil syndrome (7), trichuriasis (7), chronic active epstein-barr virus infection (6), trachoma (6)

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 5.98 RPKM in Lung
Total median expression: 21.41 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -3.5032-0.109 Picture PostScript Text
3' UTR -163.90605-0.271 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR000898 - Indolamine_dOase

Pfam Domains:
PF01231 - Indoleamine 2,3-dioxygenase

SCOP Domains:
140959 - Indolic compounds 2,3-dioxygenase-like

Protein Data Bank (PDB) 3-D Structure
MuPIT help
2D0T - X-ray MuPIT 2D0U - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on P14902
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGD    
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0004833 tryptophan 2,3-dioxygenase activity
GO:0009055 electron carrier activity
GO:0016491 oxidoreductase activity
GO:0020037 heme binding
GO:0033754 indoleamine 2,3-dioxygenase activity
GO:0046872 metal ion binding
GO:0051213 dioxygenase activity

Biological Process:
GO:0002376 immune system process
GO:0002534 cytokine production involved in inflammatory response
GO:0002666 positive regulation of T cell tolerance induction
GO:0002678 positive regulation of chronic inflammatory response
GO:0002830 positive regulation of type 2 immune response
GO:0006569 tryptophan catabolic process
GO:0006954 inflammatory response
GO:0007565 female pregnancy
GO:0019441 tryptophan catabolic process to kynurenine
GO:0022900 electron transport chain
GO:0032496 response to lipopolysaccharide
GO:0032693 negative regulation of interleukin-10 production
GO:0032735 positive regulation of interleukin-12 production
GO:0033555 multicellular organismal response to stress
GO:0034276 kynurenic acid biosynthetic process
GO:0036269 swimming behavior
GO:0042130 negative regulation of T cell proliferation
GO:0043065 positive regulation of apoptotic process
GO:0055114 oxidation-reduction process
GO:0070233 negative regulation of T cell apoptotic process
GO:0070234 positive regulation of T cell apoptotic process
GO:0046006 regulation of activated T cell proliferation

Cellular Component:
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0030485 smooth muscle contractile fiber
GO:0032421 stereocilium bundle


-  Descriptions from all associated GenBank mRNAs
  M34455 - Human interferon-gamma-inducible indoleamine 2,3-dioxygenase (IDO) mRNA, complete cds.
MS997859 - Sequence 14 from Patent EP3159403.
LQ882892 - Sequence 41 from Patent WO2018160841.
AK313259 - Homo sapiens cDNA, FLJ93768, Homo sapiens indoleamine-pyrrole 2,3 dioxygenase (INDO), mRNA.
BC027882 - Homo sapiens indoleamine 2,3-dioxygenase 1, mRNA (cDNA clone MGC:34586 IMAGE:5208340), complete cds.
X17668 - Human mRNA for indoleamine 2,3-dioxygenase.
CU693308 - Synthetic construct Homo sapiens gateway clone IMAGE:100019246 5' read INDO mRNA.
HQ447286 - Synthetic construct Homo sapiens clone IMAGE:100070597; CCSB008326_01 indoleamine-pyrrole 2,3 dioxygenase (INDO) gene, encodes complete protein.
KJ891474 - Synthetic construct Homo sapiens clone ccsbBroadEn_00868 IDO1 gene, encodes complete protein.
KR710666 - Synthetic construct Homo sapiens clone CCSBHm_00015513 IDO1 (IDO1) mRNA, encodes complete protein.
AY221100 - Homo sapiens indoleamine-pyrrole 2,3 dioxygenase (INDO) mRNA, complete cds.
JF772862 - Homo sapiens clone TA indolamine 2,3 dioxygenase (IDO1) mRNA, complete cds.
LC420315 - Homo sapiens IDO1 mRNA for indoleamine 2,3-dioxygenase 1, complete cds.
DI440227 - KR 1020140074330-A/6: Means and methods for treating and/or preventing natural AHR ligand-dependent cancer.
HW795470 - JP 2014526450-A/6: Means and methods for treating and/or preventing natural AHR ligand-dependent cancer.
JB816465 - Sequence 6 from Patent WO2013034685.
JD280007 - Sequence 261031 from Patent EP1572962.
LQ927252 - Sequence 29 from Patent WO2018191660.
MP584542 - Sequence 41 from Patent WO2020081767.

-  Biochemical and Signaling Pathways
  BioCyc Knowledge Library
NADSYN-PWY - NAD de novo biosynthesis
PWY-5651 - L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde
PWY-6309 - L-tryptophan degradation XI (mammalian, via kynurenine)
PWY66-401 - superpathway of L-tryptophan utilization
TRYPTOPHAN-DEGRADATION-1 - L-tryptophan degradation (kynurenine pathway)

Reactome (by CSHL, EBI, and GO)

Protein P14902 (Reactome details) participates in the following event(s):

R-HSA-198563 IDO1 dioxygenates L-Trp to NFK
R-HSA-71240 Tryptophan catabolism
R-HSA-6788656 Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism
R-HSA-71291 Metabolism of nitrogenous molecules
R-HSA-1430728 Metabolism

-  Other Names for This Gene
  Alternate Gene Symbols: E5RGR8, ENST00000518237.1, ENST00000518237.2, ENST00000518237.3, ENST00000518237.4, ENST00000518237.5, F6M9T7, I23O1_HUMAN, IDO, IDO1 , INDO, NM_002164, P14902, Q540B4, uc323qpn.1, uc323qpn.2
UCSC ID: ENST00000518237.6_4
RefSeq Accession: NM_002164.6
Protein: P14902 (aka I23O1_HUMAN)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.